Stock Scorecard



Stock Summary for Alphatec Holdings Inc (ATEC) - $22.55 as of 11/28/2025 8:46:01 PM EST

Total Score

5 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ATEC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ATEC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ATEC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for ATEC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for ATEC (39 out of 100)

Stock Price Rating (Max of 10) 7
Historical Stock Price Rating (Max of 10) 5
Stock Price Trend (Max of 10) 9
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for ATEC

47,106 RSUs Granted — Alphatec Holdings Announces Q3 2025 Results Date and Oct 30 Webcast - Stock Titan 10/16/2025 8:10:00 PM
Alphatec Holdings (ATEC) Receives Analyst Rating Update from Wells Fargo | ATEC Stock News 10/16/2025 1:47:00 PM
Alphatec (NASDAQ:ATEC) Receives “Sell (D-)” Rating from Weiss Ratings 10/15/2025 6:59:00 AM
Alphatec Q2 2025 slides reveal positive cash flow and record revenue growth - Investing.com 10/14/2025 11:48:00 PM
Alphatec Q2 2025 slides reveal positive cash flow and record revenue growth - Investing.com Australia 10/14/2025 11:44:00 PM
Earnings call transcript: Alphatec Holdings Q2 2025 shows robust growth - Investing.com 10/14/2025 10:38:00 PM
Alphatec (NASDAQ:ATEC) Stock Price Passes Above 200-Day Moving Average – Time to Sell? 10/14/2025 9:04:00 AM
Alphatec Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo 10/12/2025 8:01:00 PM
ATEC Launches EOS InsightTM, an End-To-End Spine Surgery Platform Powered by EOS Imaging and AI 12/31/2024 11:59:00 PM
ATEC Reports First Quarter 2024 Financial Results and Raises Full-Year Guidance 12/31/2024 11:59:00 PM

Financial Details for ATEC

Company Overview

Ticker ATEC
Company Name Alphatec Holdings Inc
Country USA
Description Alphatec Holdings, Inc., based in Carlsbad, California, is a pioneering medical technology company dedicated to the development and commercialization of advanced spinal surgical solutions. The firm emphasizes innovation to significantly improve patient outcomes, offering a comprehensive suite of products designed to address diverse spinal disorders. With a strong commitment to research and development and a robust product pipeline, Alphatec is strategically positioned to leverage the increasing demand within the orthopedic device market, presenting a compelling investment opportunity for institutional investors focused on the evolving health tech landscape.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 9/30/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 22.55
Price 4 Years Ago 11.43
Last Day Price Updated 11/28/2025 8:46:01 PM EST
Last Day Volume 768,815
Average Daily Volume 2,729,142
52-Week High 22.66
52-Week Low 8.70
Last Price to 52 Week Low 159.20%

Valuation Measures

Trailing PE N/A
Industry PE 45.47
Sector PE 89.93
5-Year Average PE -83.86
Free Cash Flow Ratio 21.48
Industry Free Cash Flow Ratio 27.76
Sector Free Cash Flow Ratio 29.09
Current Ratio Most Recent Quarter 1.99
Total Cash Per Share 1.05
Book Value Per Share Most Recent Quarter 0.08
Price to Book Ratio 291.65
Industry Price to Book Ratio 4.37
Sector Price to Book Ratio 33.13
Price to Sales Ratio Twelve Trailing Months 4.61
Industry Price to Sales Ratio Twelve Trailing Months 5.94
Sector Price to Sales Ratio Twelve Trailing Months 16.04
Analyst Buy Ratings 6
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 148,550,000
Market Capitalization 3,349,802,500
Institutional Ownership 73.61%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 2.43%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 13.14%
Reported EPS 12 Trailing Months -1.04
Reported EPS Past Year -0.04
Reported EPS Prior Year -0.97
Net Income Twelve Trailing Months -154,961,000
Net Income Past Year -162,123,000
Net Income Prior Year -186,638,000
Quarterly Revenue Growth YOY 30.40%
5-Year Revenue Growth 40.07%
Operating Margin Twelve Trailing Months -4.79%

Balance Sheet

Total Cash Most Recent Quarter 155,741,000
Total Cash Past Year 138,840,000
Total Cash Prior Year 220,970,000
Net Cash Position Most Recent Quarter -339,276,000
Net Cash Position Past Year -435,682,000
Long Term Debt Past Year 574,522,000
Long Term Debt Prior Year 511,035,000
Total Debt Most Recent Quarter 495,017,000
Equity to Debt Ratio Past Year 0.02
Equity to Debt Ratio Most Recent Quarter 0.02
Total Stockholder Equity Past Year 9,434,000
Total Stockholder Equity Prior Year 101,719,000
Total Stockholder Equity Most Recent Quarter 11,506,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months -14,000
Free Cash Flow Per Share Twelve Trailing Months 0.00
Free Cash Flow Past Year -137,787,000
Free Cash Flow Prior Year -165,460,000

Options

Put/Call Ratio 0.05
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 1.16
MACD Signal 1.16
20-Day Bollinger Lower Band 10.01
20-Day Bollinger Middle Band 15.98
20-Day Bollinger Upper Band 21.95
Beta 1.10
RSI 74.20
50-Day SMA 12.71
150-Day SMA 12.58
200-Day SMA 11.79

System

Modified 11/28/2025 5:56:05 PM EST